Evaluation of bcl-2 gene expression in papilloma of larynx in children

G Niedzielska1, J Kocki

  • 1Department of Paediatric Otolaryngology, Phoniatry and Audiology, University Medical School, ul. Chodzki 2, 20-0093, Lublin, Poland.

Insights

The bcl-2 gene, which inhibits apoptosis (programmed cell death), was found in all laryngeal papilloma cells studied. This suggests bcl-2 may drive tumor growth and resistance to treatment in these neoplasms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Apoptosis, or programmed cell death, is crucial for regulating cell numbers.
  • Neoplastic cells can resist apoptosis, contributing to drug resistance.
  • The bcl-2 gene and its protein product inhibit apoptosis, promoting cell survival.

Purpose of the Study:

  • To investigate the expression of the bcl-2 gene in laryngeal papilloma cells.
  • To explore the potential role of bcl-2 in the pathogenesis of laryngeal papillomas.

Main Methods:

  • RNA isolation using the Chomczynski and Sacchi method.
  • Gene expression analysis via reverse transcription polymerase chain reaction (RT-PCR).
  • Identification of bcl-2 gene products on agarose gel.

Main Results:

  • bcl-2 gene expression was confirmed in all investigated laryngeal papilloma samples.
  • The presence of bcl-2 protein suggests a mechanism for apoptosis inhibition in these tumors.

Conclusions:

  • bcl-2 gene expression is a common feature in laryngeal papillomas.
  • Inhibition of apoptosis by bcl-2 may contribute to the proliferation and treatment resistance of laryngeal neoplasms.